Induction Chemotherapy in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma
Prospective Randomized Trial Comparing Induction Chemotherapy Plus Concurrent Chemoradiotherapy With Concurrent Chemoradiotherapy in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma
Sponsor: Cancer Hospital of Guangxi Medical University
Listed as NCT01245959, this PHASE3 trial focuses on Nasopharyngeal Carcinoma and remains ongoing. Sponsored by Cancer Hospital of Guangxi Medical University, it has been updated 7 times since 2011, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Unknown PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE3
Status: Unknown Status → Unknown
-
Nov 2022 — Jul 2024 [monthly]
Unknown Status PHASE3
-
Jan 2021 — Nov 2022 [monthly]
Unknown Status PHASE3
-
Jun 2018 — Jan 2021 [monthly]
Unknown Status PHASE3
▶ Show 2 earlier versions
-
May 2018 — Jun 2018 [monthly]
Unknown Status PHASE3
Status: Active Not Recruiting → Unknown Status
-
Jan 2017 — May 2018 [monthly]
Active Not Recruiting PHASE3
First recorded
Jan 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Cancer Hospital of Guangxi Medical University
- Central South University
- First People's Hospital of Foshan
- Fudan University
- Guangzhou Medical University
- Huazhong University of Science and Technology
- Jiangsu Cancer Institute & Hospital
- Jiangxi Provincial Cancer Hospital
- Peking University Cancer Hospital & Institute
- Sun Yat-sen University
- The Third Affiliated Hospital of Harbin Medical University
- West China Hospital
- Zhejiang Cancer Hospital
For direct contact, visit the study record on ClinicalTrials.gov .